期刊文献+

HSV-TK/HSV-sr39TK基因工程T细胞的研制 被引量:2

Generation of genetic engineering T lymphocyte containing HSV-TK or HSV-sr39TK gene mediated by lentiviral vectors
下载PDF
导出
摘要 目的:制备慢病毒载体为基础的野生型及突变型单纯疱疹病毒胸苷激酶(HSV-TK/HSV-sr39TK)基因工程T细胞(TK+T及sr39TK+T细胞),观察给予前体药物丙氧鸟苷/无环鸟苷后小鼠T淋巴细胞对其敏感性及存活情况。方法:构建含HSV-TK/HSV-sr39TK及内部核糖体进入位点序列(IRES)和绿色荧光蛋白基因(GFP)的双顺反子慢病毒载体;采用磷酸钙沉淀法将慢病毒载体三质粒转染293T细胞,收集病毒上清感染刀豆蛋白刺激的小鼠T淋巴细胞,给予不同浓度的前体药物GCV/ACV,用Cell Counting Kit(CCK-8)等方法检测T细胞的存活率。结果:转染293T细胞后,病毒滴度达106/U/ml以上;含不同启动子的病毒载体转染效率CMV>PUB>PGK,对小鼠T淋巴细胞的感染效率以CMV启动子最高;IC50值的测定显示sr39TK+T细胞对GCV和ACV的敏感性较TK+T细胞分别提高约2.5和17.4倍;ACV及GCV浓度在1~10μmol/Lsr39TK+T细胞活率下降最为明显,ACV组细胞存活率由(98.4±2.7)%下降为(49.9±5.9)%,GCV组由(97.9%±2.7)%下降为(33.7±5.3)%,P<0.05,随ACV及GCV浓度的增加,细胞活率下降趋势有所减弱;TK+T细胞对GCV敏感,细胞活率由(97.9±2.7)%下降为(38.4±5.5)%,(P<0.05),对ACV不敏感,细胞活率由(98.4±2.7)%下降为(73.8±7.4)%,P>0.05。结论:成功构建了HSV-TK/HSV-sr39TK基因工程T细胞,不同启动子对慢病毒载体在293T细胞的转染效率、转导自杀基因在T淋巴细胞内的表达均有影响;HSV-sr39TK+T细胞对GCV和ACV的敏感性高于TK+T细胞。 Objective:The genetic engineering T lymphocytes containing herpes simplex virus thymidine kinase gene (TK^+T cells) or mutant herpes simplex virus thymidine kinase(HSV-sr39TK) gene( sr39 TK^+ T cells) were generated and the survival rate of T cells after giving the predrug Ganciclovir/Acyclovir(GCV/ACV) was observed. Methods:The bicistronic lentiviral vectors containing HSV-TK/HSV-sr39TK and internal ribosomal entry site-green fluorescent protein gene (IRES-GFP) were constructed. Human embryonic kidney 293T cells were co-transfected by the three-plasmid system of lentiviral vector including the packaging plasmid ANRF, the vector plasmid and the envelope plasmid VSV-G by calcium phosphate DNA precipitation, the mouse T lymphecytes stimulated by concanavalin A were infected by the virus supernatant and diversity concentration predrug GCV/ACV was co-incubated with TK^+ T cells or sr39TK^+T cells, the killing effects was estimated by Cell Count kit-8 (CCK-8). Results:The titres of lentiviral vector were above 10^6 IU/ml after packaging. The efficiency of different internal promoters to drive the expression of the target gene was CMV 〉 PUB 〉 PGK. The determination of IC50 showed that the sensitivity of sr39TK^+ T cells to GCV and ACV were higher than TK ^+ T cells about 2. 5 and 17.4 times respectively. The survival rates of sr39TK^+ T cells declined significantly when the concentrations of ACV/GCV were between 1 - 10μmol/L, The T cell survival rates in ACV group declined from (98.4 ± 2.7) % to (49. 9 ± 5.9) % and GCV group from (97.9% ±2. 7)% to (33.7 ±5. 3)% ,P 〈0. 05. When the concentrations of ACV/GCV were increased, further decline ofT cell survival rates became unobvious. TK^+ T ceils were sensitive to GCV, the survival rate of T cells declined from (97.9 ± 2.7 ) % to (38.4 ± 5.5 ) %, ( P 〈 0.05 ) but they were not sensitive to ACV, the survival rate of T cells declined from ( 98.4 ± 2.7 ) % to (73. 8 ± 7.4) %, ( P 〉 0. 05 ). Conclusions: The genetic engineering T cells containing HSV-TK/HSV-sr39TK genes were generated. Different internal promoters had different effects on transfection efficiency and driving the expression of HSV-TK/HSV-sr39TK genes in T cells. HSV-sr39TK^+T cells were more sensitive to GCV and ACV than TK^+T cells.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2007年第11期999-1003,共5页 Chinese Journal of Immunology
基金 国家自然科学基金资助项目(编号:30170389) 江苏省"135"医学重点人才基金资助项目(编号RC2002080)
关键词 单纯疱疹病毒胸苷激酶 突变型 野生型 基因工程T细胞 慢病毒载体 Herpes simplex virus thymidine kinase gene Wild-type Mutant-type Genetic engineering T lymphocytes Lentiviral vector
  • 相关文献

参考文献13

  • 1Appelbaum F R.Haematopoietic cell transplantation as immunotherapy[J].Nature,2001;411(6835):385-389.
  • 2Campbell J D,Cook G,Holyoake T L.Evolution of bone marrow transplantation-the original immunotherapy[J].Trends Immunol,2001;22(2):88-92.
  • 3Little M T,Storb R.History of haematopoietic stem-cell transplantation[J].Nat Rev Cancer,2002;2(3):231-238.
  • 4Harrington K,Alvarez-Vallina L,Crittenden M et al.Cells as vehicles for cancer gene therapy:the missing link between targeted vectors and systemic delivery?[J].Hum Gene Ther,2002;13(11):1263-1280.
  • 5Kirn D,Niculescu-Duvaz I,Hallden G et al.The emerging fields of suicide gene therapy and virotherapy[J].Trends Mol Med,2002;8(4 Suppl):S68-73.
  • 6Tiberghien P,Ferrand C,Lioure B et al.Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft[J].Blood,2001;97(1):63-72.
  • 7徐开林,潘秀英,杨宇娟,鹿群先,李振宇,何徐彭.慢病毒介导的突变型胸苷激酶对T淋巴细胞杀伤作用的实验研究[J].中华血液学杂志,2005,26(11):678-681. 被引量:3
  • 8Marina I Garin,Elaine Garrett,Pierre Tiberghien et al.Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene[J].Blood,2001;97(1):122-129.
  • 9Tiberghien P,Reynolds C W,Keller J et al.Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes:an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?[J].Blood,1994;84(4):1333-1341.
  • 10Margaret E B,Mark S K,Peter Sabo.Herpes Simplex Virus-1 Thymidine Kinase Mutants Created by Semi-Random Sequence Mutagenesis:Improve Prodrug-mediated Tumor Cell Killing[J].Cancer Res,2001;61(7):3022-3026.

二级参考文献16

  • 1Tiberghien P, Ferrand C, Lioure B, et al. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood, 2001,97: 63-72.
  • 2Garin MI, Garrett E, Tiberghien P, et al. Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene.Blood, 2001,97:122-129.
  • 3Black ME, Kokoris MS, Sabo P. Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing. Cancer Res, 2001, 61:3022-3026.
  • 4Varmus H. Retroviruses. Science,1988 ,240 :1427-1435.
  • 5Vile RG, Russell SJ. Retroviruses as vectors. Br Med Bull, 1995,51:12-30.
  • 6Scherr M, Eder M. Gene transfer into hematopoietic stem cells using lentiviral vectors. Curr Gene Ther, 2002,2:45-55.
  • 7Logan AC, Haas DL, Kafri T, et al. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. J Virol, 2004, 78:8421-8436.
  • 8J萨姆布鲁克 E F 弗里奇 T 曼尼阿蒂斯著 金冬雁 黎孟枫译.分子克隆实验指南:第2版[M].北京:科学出版社,1995.860.
  • 9Vanden-Driessche T, Vanslembrouck V, Goovaerts I, et al.Long-term expression of human coagulation factor Ⅷ and correction of hemophilia A after in vivo retroviral gene transfer in factor Ⅷ-deficient mice. Proc Natl Acad Sci U S A, 1999, 96:10379-10384.
  • 10Connelly S, Smith TA, Dhir G, et al. In vivo delivery and expression of physiological levels of functional human factor Ⅷ in mice. Hum GeneTher, 1995,6:185-193.

共引文献21

同被引文献10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部